Methylation clocks for evaluation of anti-aging interventions.

Area of Science:

• Epigenetics and aging research
• Molecular biology of aging
• Evolutionary biology

Background:

• Methylation clocks are used to assess anti-aging interventions without mortality data.
• Epigenetic methylation is under strong evolutionary selection.
• Late-life methylation changes may indicate either programmed self-destruction or repair activation.

Purpose of the Study:

• To propose that both programmed self-destruction (Type 1) and self-repair (Type 2) epigenetic changes occur with aging.
• To argue that only Type 1 changes are suitable for developing methylation clocks for anti-aging interventions.
• To address the challenge of differentiating Type 1 from Type 2 epigenetic changes.

Main Methods:

• Theoretical analysis of epigenetic changes in aging.
• Evaluation of existing literature on stochastic epigenetic drift.
• Construction of a methylation drift measure using Conboy methodology and a methylation database.

Main Results:

• Type 1 epigenetic changes reflect programmed self-destruction and are useful for anti-aging clocks.
• Type 2 epigenetic changes reflect self-repair activation and are not suitable for anti-aging clocks.
• True methylation drift, as measured, shows a low correlation with age, rendering it unsuitable for practical use.

Conclusions:

• Distinguishing between Type 1 and Type 2 epigenetic changes is a critical challenge for epigenetic clock development.
• Directed epigenetic changes, not stochastic drift, are likely responsible for aging-related methylation patterns.
• Current measures of methylation drift are not effective for assessing anti-aging interventions.